We report a case of a 62-year-old female with seizures and encephalitis. Molecular testing of the patient's cerebrospinal fluid was positive for both herpes simplex virus 1 and 2 (HSV-1 and HSV-2). To our knowledge, this is the first report of simultaneous detection of HSV-1 and HSV-2 in cerebrospinal fluid.

Herpes simplex virus 2 (HSV-2) is a well-known cause of neurological complications. This case study describes the first reported reactivated HSV-2 myelitis, which was induced by immunosuppression due to sepsis. During treatment meningococcal meningitis, patient developed quadriparesis and later diagnosed as mimicking ICU-acquired weakness. The emphasizes importance excluding viral myelitis befo...

We report the case of a 23-year-old male burn patient with an unusual herpes simplex virus (HSV) skin manifestation. The clinical symptoms and results of HSV type 1 (HSV-1) UL23 polymorphism analysis from saliva and lesional skin underscores the need for performing molecular analysis of HSV-1 infections in burned patients presenting unusual skin lesions.

The interferon (IFN) response to viral pathogens is critical for host survival. In humans and mouse models, defects in IFN responses can result in lethal herpes simplex virus 1 (HSV-1) infections, usually from encephalitis. Although rare, HSV-1 can also cause fulminant hepatic failure, which is often fatal. Although herpes simplex encephalitis has been extensively studied, HSV-1 generalized inf...

objective(s) herpes simplex viruses (hsvs) have widespread and ubiquitous prevalence in the human population and they have received a great deal of attention due to the range of diseases, they caused as a result of an infection. it seems that the fast and reliable diagnostic methods are needed for detecting the herpes simplex virus type 1 (hsv1) antibodies especially in patients with hsv enceph...

Herpes Simplex Virus type 1 (HSV-1) is usually the cause of oral infection. This infection oftenprecedes development this chronic anemia, and it reasonable that blood in circulation through virusinfectedtissue becomes contaminated with virus particles on red cell surface. These virus-contaminated redblood cells may stimulate reticuloendothelial system to produce antibodies destroy andlead anemi...

BACKGROUND A herpes simplex virus (HSV)-2 candidate vaccine consisting of glycoprotein D (gD2) in alum and monophosphoryl lipid A (MPL) reduced genital herpes disease in HSV-1-seronegative women but not in men or HSV-1-seropositive women. METHODS To determine the effect of HSV-1 serostatus on effectiveness of different vaccines, we tested gD2 in alum/MPL, gD2 in Freund's adjuvant, and dl5-29 ...

HERPES SIMPLEX VIRUS TYPE 2 (HSV-2) seroprevalence has increased by 32% in the last decade. Overall, HSV-2 seroprevalence is 22% in the general US adult population, and in some populations, such as sexually transmitted disease (STD) clinic attendees, seroprevalence varies between 30% and 50%. Concomitant with this increase in genital herpes has been an increase in reported cases of neonatal her...

The Viper HSV-Q(x) assay was evaluated for the detection of herpes simplex virus 1 (HSV-1) and HSV-2 in specimens from oral, anogenital, and other miscellaneous sites. The HSV-Q(x) assay was found to be highly sensitive and accurate; however, a gray zone may be required for specimens with values falling between 50 and 800 maximum relative fluorescence units.